AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Janupil-M 50/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Psychotropics India Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Janupil-M 50/1000mg Tablet

Metformin/Glibenclamide 50/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially decreasing cardiovascular event risk. This medication may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming this medicine with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include nausea, vomiting, diarrhea, abdominal upset, headache, and pharyngitis. Hypoglycemia, particularly when used with insulin or sulfonylureas, is a possibility; learn to recognize and manage this condition. This medication isn't universally suitable. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before initiating treatment. Pregnant or lactating individuals require medical consultation. Interactions with other drugs are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Janupil-M 50/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Janupil-M 50/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Janupil-M 50/1000mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Janupil-M 50/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Janupil-M 50/1000mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Janupil-M 50/1000mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Janupil-M 50/1000mg Tablet works:

Janupil-M 50/1000mg tablets combine sitagliptin and metformin to effectively manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Janupil-M 50/1000mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Janupil-M 50/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Janupil-M 50/1000mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Janupil-M 50/1000mg tablets, potentially requiring dosage modification. A physician's consultation is recommended. Janupil-M 50/1000mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from taking Janupil-M 50/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Janupil-M 50/1000mg Tablet :

Should you forget to take your Janupil-M 50/1000mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Janupil-M 50/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Janupil-M 50/1000mg Tablet

Janupil-M 50/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when coupled with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged Janupil-M 50/1000mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Janupil-M 50/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with allergies to Janupil-M 50/1000mg Tablet components, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Janupil-M 50/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Janupil-M 50/1000mg tablets. This occurs due to excessive blood lactic acid. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Janupil-M 50/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Janupil-M 50/1000mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Janupil-M 50/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Janupil-M 50/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Janupil-M 50/1000mg Tablets. This is due to a buildup of lactic acid in the blood and is rare, but more likely in patients with kidney disease, older individuals, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Janupil-M 50/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janupil-M 50/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Janupil-M 50/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Janupil-M 50/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Janupil-M 50/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Janupil-M 50/1000mg tablets. This occurs due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged use of Janupil-M 50/1000mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Janupil-M 50/1000mg Table...
292